PLC
IMA

Peapod Lane Capital’s ImageneBio Inc IMA Stock Holding History

Peapod Lane Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,703
Closed -$379K – 58
2025
Q1 		$379K Sell
24,703
-17,619
-42% -$304K 0.43% 59
2024
Q4 		$833K Buy
+42,322
New +$856K 0.83% 48

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Peapod Lane Capital's IMA Position: Q2 2025 in Review

Peapod Lane Capital sold out of ImageneBio Inc (IMA) in Q2 2025, closing a stake of 24,703 shares — an estimated $379K sold.

Peapod Lane Capital first reported a position in IMA in Q4 2024 and held it in 2 quarters. The position peaked at $833K in Q4 2024. 40 funds tracked by Wall St. Rank hold IMA as of Q2 2025.

  • Peapod Lane Capital reported no remaining ImageneBio Inc position as of Q2 2025 after selling out during the quarter.
  • Peapod Lane Capital sold 24,703 ImageneBio Inc shares in Q2 2025, an estimated $379K.
  • Peapod Lane Capital first reported a position in ImageneBio Inc in Q4 2024 and held it in 2 quarters.
  • Peapod Lane Capital's ImageneBio Inc position peaked at $833K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2025.

Based on Peapod Lane Capital's 13F filing for Q2 2025, filed 31 Jul 2025.